Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Enrollment begins in phase I study of AG-946

Sep. 9, 2020

Midwestern University describes isotopically stabilized tetronimide compounds

Sep. 7, 2020

S-62798 demonstrates efficacy in mouse model of thromboembolism

Sep. 7, 2020

University of California patents lentiviral vectors for hemoglobinopathies

Sep. 4, 2020

LNP-023 demonstrates efficacy, both as add-on and monotherapy, in patients with PNH

Sep. 3, 2020

Bristol-Myers Squibb reports phase I data for the antithrombotic milvexian

Sep. 2, 2020

First clinical data for TAFIa inhibitor S-62798 presented

Sep. 2, 2020

FDA clears IND for clinical development of OMS-906 for PNH

Sep. 1, 2020

Discovery of novel HIF-PHD2 inhibitors for the treatment of anemia

Sep. 1, 2020

Early clinical reports suggest utility of Aggrastat for COVID-19-related thrombotic complications

Aug. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...